piribedil has been researched along with Bradykinesia in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costentin, J | 1 |
| Marçais, H | 1 |
| Protais, P | 1 |
| Schwartz, JC | 1 |
1 other study available for piribedil and Bradykinesia
| Article | Year |
|---|---|
Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors?
Topics: Amphetamine; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interac | 1977 |